Processa Pharmaceuticals (PCSA) Short term Debt (2012 - 2021)
Processa Pharmaceuticals' (PCSA) quarterly Short term Debt came in at $1772.0 in Q4 2021, down 97.46% YoY from $69858.0 in Q4 2020, and down 84.91% on a QoQ basis from $11742.0 in Q2 2021.
Processa Pharmaceuticals (PCSA) Short term Debt (2012 - 2021) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 10 years of Short term Debt data on file, last reported at $1772.0 in Q4 2021.
- Quarterly Short term Debt fell 97.46% year-over-year to $1772.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $1772.0 (down 97.46% YoY) and the FY2021 annual result came in at $1772.0, down 97.46% from the prior year.
- Short term Debt fell to $1772.0 in Q4 2021, from $11742.0 in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $803573.0 in Q1 2020 to a low of $100.0 in Q3 2018.
- A 5-year average of $254214.7 and a median of $69858.0 in 2020 frame the typical range for Short term Debt.
- Annual changes were most pronounced in 2017 — Short term Debt plunged 99.9% — and 2018, when it soared 52652.29%.
- Tracing PCSA's Short term Debt over 5 years: stood at $436.0 in 2017, then soared by 52652.29% to $230000.0 in 2018, then soared by 248.91% to $802503.0 in 2019, then tumbled by 91.29% to $69858.0 in 2020, then slumped by 97.46% to $1772.0 in 2021.
- The last three Short term Debt figures came in at $1772.0 (Q4 2021), $11742.0 (Q2 2021), and $41258.0 (Q1 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | Processa Pharmaceuticals | 5.72 Mn | 5.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 1,772.00 |
| Jun 30, 2021 | 11,742.00 |
| Mar 31, 2021 | 41,258.00 |
| Dec 31, 2020 | 69,858.00 |
| Sep 30, 2020 | 762,229.00 |
| Jun 30, 2020 | 500,000.00 |
| Mar 31, 2020 | 803,573.00 |
| Dec 31, 2019 | 802,503.00 |
| Sep 30, 2019 | 25,727.00 |
| Jun 30, 2019 | 1,336.00 |
| Mar 31, 2019 | 230,000.00 |
| Dec 31, 2018 | 230,000.00 |
| Sep 30, 2018 | 100.00 |
| Jun 30, 2018 | 1,116.00 |
| Dec 31, 2017 | 436.00 |
| Jun 30, 2017 | 420,000.00 |
| Mar 31, 2017 | 420,000.00 |
| Dec 31, 2016 | 420,000.00 |
| Sep 30, 2016 | 1.61 Mn |
| Jun 30, 2016 | 1.61 Mn |